Polycaprolactone-bioactive glass hybrids as a controlled release platform for the delivery of therapeutics in bone tissue engineering. - Université Clermont Auvergne
Communication Dans Un Congrès Année : 2021

Polycaprolactone-bioactive glass hybrids as a controlled release platform for the delivery of therapeutics in bone tissue engineering.

Domaines

Chimie Sciences du Vivant [q-bio] Physique [physics]

Edouard Jallot  : Connectez-vous pour contacter le contributeur

https://uca.hal.science/hal-03549046

Soumis le : lundi 31 janvier 2022-11:03:59

Dernière modification le : jeudi 11 avril 2024-13:18:12

Fichier non déposé

Dates et versions

hal-03549046 , version 1 (31-01-2022)

Identifiants

  • HAL Id : hal-03549046 , version 1

Citer

Lukas Gritsch, Cédric Bossard, Christiane Forestier, Edouard Jallot, Henri Granel, et al.. Polycaprolactone-bioactive glass hybrids as a controlled release platform for the delivery of therapeutics in bone tissue engineering.. ESB 2021, 31th Conference of the European Society for Biomaterials, Sep 2021, Porto, Portugal. ⟨hal-03549046⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

IN2P3 PRES_CLERMONT LPC-CLERMONT CNRS LMGE UNH INRAE ALIMH
54 Consultations
0 Téléchargements

Partager

More